SAGE - Sage Therapeutics, Inc.

QQQ $ 454.82 $ 1.24 (0.27 %)

DIA $ 398.57 $ 1.27 (0.33 %)

SPY $ 530.36 $ 0.59 (0.11 %)

TLT $ 91.26 $ 1.07 (1.17 %)

GLD $ 225.37 $ -1.95 (-0.9 %)

Previous Close

$ 10.68

Open

$ 11.02

Bid

$ 10.64 x 100

Ask

$ 10.68 x 200

Day's Range

$ 10.66 - $ 11.39

52 Week Range

$ 10.62 - $ 59.99

Volume

1,674,625

Average Volume

Market Cap

642.25M

Beta (5Y Monthly)

$ 1.32

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	04-25-2024	03-31-2024	10-Q
2	02-14-2024	12-31-2023	10-K
3	11-07-2023	09-30-2023	10-Q
4	08-07-2023	06-30-2023	10-Q
5	05-02-2023	03-31-2023	10-Q
6	02-16-2023	12-31-2022	10-K
7	11-08-2022	09-30-2022	10-Q
8	08-02-2022	06-30-2022	10-Q
9	05-03-2022	03-31-2022	10-Q
10	02-24-2022	12-31-2021	10-K
11	11-02-2021	09-30-2021	10-Q
12	08-03-2021	06-30-2021	10-Q
13	05-04-2021	03-31-2021	10-Q
14	02-24-2021	12-31-2020	10-K
15	11-05-2020	09-30-2020	10-Q
16	08-10-2020	06-30-2020	10-Q
17	05-07-2020	03-31-2020	10-Q
18	02-27-2020	12-31-2019	10-K
19	11-12-2019	09-30-2019	10-Q
20	08-06-2019	06-30-2019	10-Q
21	05-02-2019	03-31-2019	10-Q
22	02-19-2019	12-31-2018	10-K
23	11-06-2018	09-30-2018	10-Q
24	08-07-2018	06-30-2018	10-Q
25	05-03-2018	03-31-2018	10-Q
26	02-22-2018	12-31-2017	10-K
27	11-02-2017	09-30-2017	10-Q
28	08-03-2017	06-30-2017	10-Q
29	05-10-2017	03-31-2017	10-Q
30	02-24-2017	12-31-2016	10-K
31	11-03-2016	09-30-2016	10-Q
32	08-09-2016	06-30-2016	10-Q
33	05-06-2016	03-31-2016	10-Q
34	02-29-2016	12-31-2015	10-K
35	11-06-2015	09-30-2015	10-Q
36	08-12-2015	06-30-2015	10-Q
37	05-15-2015	03-31-2015	10-Q
38	03-06-2015	12-31-2014	10-K
39	11-13-2014	09-30-2014	10-Q
40	08-14-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Cracking The Code: Understanding Analyst R...
05/29/2024 13:01:19

Citigroup Initiates Coverage On Sage Thera...
05/29/2024 10:43:54

Citigroup analyst David Hoang initiates coverage on Sage Therapeutics (NASDAQ:SAGE) with a Sell rating and announces Price T...

Baird Initiates Coverage On Sage Therapeut...
05/29/2024 09:10:32

Baird analyst Joel Beatty initiates coverage on Sage Therapeutics (NASDAQ:SAGE) with a Neutral rating and announces Price Ta...

top-5-health-care-stocks-which-could-rescue-your-portfolio-this-month

Top 5 Health Care Stocks Which Could Rescu...
05/21/2024 12:39:25

Sage Therapeutics CE Says Co Open To Partn...
05/14/2024 17:31:54

- Bloomberg

JP Morgan Maintains Overweight on Sage The...
05/01/2024 15:24:00

JP Morgan analyst Anupam Rama maintains Sage Therapeutics (NASDAQ:SAGE) with a Overweight and lowers the price target from $...

HC Wainwright & Co. Maintains Neutral on S...
04/26/2024 18:19:51

HC Wainwright & Co. analyst Douglas Tsao maintains Sage Therapeutics (NASDAQ:SAGE) with a Neutral and lowers the price t...

Goldman Sachs Maintains Neutral on Sage Th...
04/26/2024 16:06:19

Goldman Sachs analyst Salveen Richter maintains Sage Therapeutics (NASDAQ:SAGE) with a Neutral and lowers the price target f...

RBC Capital Maintains Sector Perform on Sa...
04/26/2024 15:56:06

RBC Capital analyst Brian Abrahams maintains Sage Therapeutics (NASDAQ:SAGE) with a Sector Perform and lowers the price targ...

Truist Securities Maintains Hold on Sage T...
04/26/2024 15:55:57

Truist Securities analyst Joon Lee maintains Sage Therapeutics (NASDAQ:SAGE) with a Hold and lowers the price target from $2...

Mizuho Maintains Neutral on Sage Therapeut...
04/26/2024 13:14:26

Mizuho analyst Uy Ear maintains Sage Therapeutics (NASDAQ:SAGE) with a Neutral and lowers the price target from $20 to $18.

Canaccord Genuity Maintains Hold on Sage T...
04/26/2024 12:56:31

Canaccord Genuity analyst Sumant Kulkarni maintains Sage Therapeutics (NASDAQ:SAGE) with a Hold and lowers the price target ...

Needham Reiterates Hold on Sage Therapeutics
04/26/2024 09:29:38

Needham analyst Ami Fadia reiterates Sage Therapeutics (NASDAQ:SAGE) with a Hold.

Needham Reiterates Hold on Sage Therapeutics
04/25/2024 11:58:18

Needham analyst Ami Fadia reiterates Sage Therapeutics (NASDAQ:SAGE) with a Hold.

Sage Therapeutics Expects Cash & Equivalen...
04/25/2024 10:40:29

The Company does not anticipate receipt of any additional milestone payments from collaborations in the remainder of 2024. The ...

Sage Therapeutics Q1 2024 GAAP EPS $(1.80)...
04/25/2024 10:31:23

Sage Therapeutics (NASDAQ:SAGE) reported quarterly losses of $(1.80) per share which missed the analyst consensus estimate of $...

hilton-worldwide-reports-upbeat-results-joins-hasbro-vertiv-holdings-and-other-big-stocks-moving-higher-on-wednesday

Hilton Worldwide Reports Upbeat Results, J...
04/24/2024 15:19:08

12-health-care-stocks-moving-in-wednesdays-pre-market-session

12 Health Care Stocks Moving In Wednesday'...
04/24/2024 12:06:37

netflix-on-semiconductor-and-other-big-stocks-moving-lower-in-fridays-pre-market-session

Netflix, ON Semiconductor And Other Big St...
04/19/2024 11:58:31

Scotiabank Maintains Sector Outperform on ...
04/18/2024 13:19:26

Scotiabank analyst George Farmer maintains Sage Therapeutics (NASDAQ:SAGE) with a Sector Outperform and lowers the price tar...